Investors

Predictive Technology Group, Inc.

Business Description

Predictive Technology Group, Inc. (PRED) through its wholly owned subsidiary Predictive Therapeutics, Inc. revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRED uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.

FINANCIAL REPORTING/DISCLOSURE

Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Sept. 30, 2017 – Quarterly Report
CIK 0001382943
Fiscal Year End 06/30
OTC Marketplace OTC Pink Current

 

PROFILE DATA

SIC – Industry Classification 2835 – Diagnostic substances
Business Status Development Stage Company a/o Sep 16, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees 27 a/o Oct. 31, 2017

 

COMPANY OFFICERS/CONTACTS

Merle Ferguson Secretary, Treasurer
Bradley Robinson President

 

COMPANY DIRECTORS

Merle Ferguson Chairman
Bradley Robinson Director

SERVICE PROVIDERS

PCAOB Auditing Firm

ACCOUNTING FIRM

  • CS&S Enterprises
  • 5840 West Craig Road,Las Vegas, NV, 89130United States

Securities - Legal

  • Law Office of Robert W. Wright
  • 716 Castro St.,Solana Beach,
    CA, 92075 United States
  • 858-353-6591

Intellectual Property - Legal

  • Wilson Sonsini Goodrich & Rosati
  • 650 Page Mill Road
    Palo Alto, CA 94304-1050
  • 650-493-9300

INVESTOR RELATIONS

DOCTORS / SCIENTIFIC / SALES INFO

  • 2749 East Parleys Way, Suite 101
    Salt Lake City UT 84109
  • 1-888-407-9761
  • 1-801-487-2477
  • info@predrx.com